Sitemap - 2025 - NPC Healthbiz Weekly
mRNA vaccines expand beyond Covid-19 into oncology and infectious diseases
From faster timelines to smarter clinical trials — How AI is revolutionizing drug discovery
Tech is transforming the pharma industry, speeding drug discovery and personalizing medicine
Revolutionizing chronic care: The next frontier in precision medicine
First AbbVie Biotech Innovators Award goes to Neuropeutics
Feds looking for more transparency in drug pricing
Pharma M&A: What's the global landscape for 2025?
Tariffs and the effect on Canadian pharma
S14 E01 Dr. Bettina Hamelin and The Role of Innovative Medicines Canada
Serving women’s health in the specialty pharma sector
Lisa Mullet on the importance of diversity in shaping healthcare
AI and the importance of data to pharma marketers
Balancing innovation and industry challenges at Eli Lilly Canada
Patient support programs essential in rare diseases
S13 E08 Tariffs and the Effect on Canadian Pharma Companies
The patient voice matters: How UCB Pharma Canada is redefining healthcare research
S13 E07 Serving Women’s Health in the Specialty Pharma Sector
Navigating pharma partnerships: Insights from KYE’s John McKendry
S13 E06 Innovation and Market Access in Pharma
On career navigation: Embracing lateral moves for future success in pharma
What’s Pharma’s role in sustaining Canadian healthcare?
Market paradox: Medical innovation soars while life sciences funding stalls
Pharma’s AI revolution: Balancing innovation and regulation
What does it take for a pharma start-up to succeed?
Reimagining patient-centricity in pharma
Reimagining workplace culture: Pharma leaders set the tone for a post-pandemic future